DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 1.54% to $9.88 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.03% to 19,733.59 and the Dow Jones Industrial Average rising 0.31% to 44,850.35.
The stock's rise snapped a four-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 84.04% short of its 52-week high of $61.90, which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.22% to $4.44, Fortress Biotech Inc. (FBIO) fell 0.83% to $1.79, and Viking Therapeutics Inc. $(VKTX)$ rose 2.57% to $34.32.
Trading volume (189,303) remained 76,595 below its 50-day average volume of 265,898.
Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 28, 2025 17:26 ET (22:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。